Eric D Donnenfeld MD
Cornea & External Disease, Refractive Surgery
Clinical professor of ophthalmology NYU
Join to View Full Profile
711 Stewart AveGarden City, NY 11530
Phone+1 516-500-4200
Fax+1 516-766-3714
Dr. Donnenfeld is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalResidency, Ophthalmology, 1984 - 1985
Zucker School of Medicine at Hofstra/Northwell/Manhattan Eye, Ear & Throat HospitalResidency, Ophthalmology, 1981 - 1984
Newton-Wellesley HospitalInternship, Internal Medicine, 1980 - 1981
Geisel School of Medicine at DartmouthClass of 1980
Certifications & Licensure
NY State Medical License 1981 - 2026
CT State Medical License 1999 - 2025
PA State Medical License 1984 - 1986
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013
- Top MD Consumers Checkbook
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Effect of Topical Fluoroquinolones on Epithelial Wound Healing After PRK Start of enrollment: 2007 Jan 01
- Artificial Tears Study in Mild to Moderate Dry Eye Patients
- Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery. Start of enrollment: 2009 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Efficacy and safety of a lipid-containing artificial tear compared with a non-lipid containing tear: a randomized clinical trial.Eric Donnenfeld, Jade Coats, Krista Barbour, Robert Ryan, Nabin R Joshi
BMC Ophthalmology. 2024-10-08 - Pharmacogenomic Analysis of Response to Topical Tumor Necrosis Factor α Antagonist Licaminlimab (OCS-02) in Dry Eye Disease [RETRACTED].Eric Donnenfeld, Christophe Baudouin, Anat Galor, Georges Weissgerber, Yunsheng He
Cornea. 2024-10-01 - Effectiveness and safety of a novel crosslinked hyaluronate canalicular gel occlusive device for dry eye.Mark Packer, Richard Lindstrom, Vance Thompson, Jai G Parekh, Preeya Gupta
Journal of Cataract and Refractive Surgery. 2024-10-01
Press Mentions
Dry Eye Breakthroughs in the MakingJanuary 14th, 2025- Navigating Through the NoiseJuly 15th, 2022
- Oculis Announces First Patient Enrolled in Phase3 OPTIMIZE Trial of OCS-01 in the Treatment of Inflammation and Pain Following Cataract SurgeryJune 27th, 2022
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
